Substituted pyrazolo [3, 4-b] pyridine compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 35/00 (2006.01) C07D 471/14 (2006.01) C07D 487/04 (2006.01) C07D 493/14 (2006.01) C07D 495/14 (2006.01)

Patent

CA 2748276

The present invention relates to substituted imidazoly 1-5,6- dihydrobenzo[n]isoquinoline compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted imidazolyl-5,6-dihydrobenzo[n]isoquinoline compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

La présente invention concerne des composés d'imidazolyl-5,6-dihydrobenzo[n]isoquinoléine substitués et des procédés de synthèse de ces composés. La présente invention concerne en outre des compositions pharmaceutiques contenant des composés d'imidazolyl-5,6-dihydrobenzo[n]isoquinoléine substitués et des procédés de traitement de troubles de prolifération cellulaire, tels que le cancer, par administration de ces composés et compositions pharmaceutiques à des sujets nécessitant ceci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted pyrazolo [3, 4-b] pyridine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrazolo [3, 4-b] pyridine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazolo [3, 4-b] pyridine compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1720227

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.